
AChR-specific immunosuppressive therapy of myasthenia gravis
Keywords: MG, myasthenia gravis; EAMG, experimental autoimmune myasthenia gravis; AChR, acetylcholine receptor; MuSK, muscle-specific kinase; LRP4, lipoprotein-related protein 4; MIR, the main immunogenic region; AChBP, acetylcholine binding protein; IFA, incomplet